Ready for Launch: Selecta Biosciences Inc. Jumps as Much as 16%

What happened Shares of Selecta Biosciences NASDAQ SELB a clinical stage biotech company focused on developing proprietary gene therapies to improve patient tolerance to treatments rocketed higher by as much as 16 during Monday s trading session after the company announced